Showing results (81-90 of 115) with videos related to
Sort By:
Pageof 12
Cancer Journal (Sudbury, Mass.)|November 6, 2002
Radiotherapy alone for lymphocyte-predominant Hodgkin's diseasePamela J Schlembach, Richard B Wilder, Dan Jones, et al.International Journal of Radiation Oncology, Biology, Physics|October 8, 2003
Stage III follicular lymphoma: long-term follow-up and patterns of failureChul S Ha, Joseph S Kong, Peter McLaughlin, et al.Leukemia & Lymphoma|April 11, 2003
Outcomes using doxorubicin-based chemotherapy with or without radiotherapy for early-stage peripheral T-cell lymphomasHoon K Lee, Richard B Wilder, Dan Jones, et al.Open Forum Infectious Diseases|February 8, 2021
Histological Evidence of Pulmonary Microthrombosis and Vasculitis in Life-Threatening Respiratory Virus DiseasesHeather W Dolby, Philippe Potey, Annika B Wilder-Smith, et al.Cancer|March 29, 2002
European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin diseaseRichard B Wilder, Pamela J Schlembach, Dan Jones, et al.International Braz J Urol : Official Journal of the Brazilian Society of Urology|September 25, 2014
External beam radiation therapy and a low-dose-rate brachytherapy boost without or with androgen deprivation therapy for prostate cancerTobin J Strom, Sean Z Hutchinson, Kushagra Shrinath, et al.Cancer|August 14, 2002
The role of local radiation therapy for mediastinal disease in adults with T-cell lymphoblastic lymphomaBouthaina S Dabaja, Chul S Ha, Deborah A Thomas, et al.Cancer|July 13, 2002
International prognostic index-based outcomes for diffuse large B-cell lymphomasRichard B Wilder, Maria A Rodriguez, L Jeffrey Medeiros, et al.Cancer|December 6, 2002
An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin diseaseGregory M Chronowski, Richard B Wilder, Susan L Tucker, et al.Current Problems in Cancer|June 15, 2010
ACR Appropriateness Criteria: follow-up of Hodgkin's lymphomaAndrea Ng, Louis S Constine, Ranjan Advani, et al.Pageof 12